ALNYLAM PHARMACEUTICALS, INC. Annual Current State and Local Tax Expense (Benefit) in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Alnylam Pharmaceuticals, Inc. annual Current State and Local Tax Expense (Benefit) history and growth rate for 2023.
Current State and Local Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.